however, is not that common. It is quite rare. One million Americans and a quarter million of British are said to be suffering from CFS. Some have estimated the prevalence to be 7 cases per 100,000 whereas some think it is much more prevalent—up to 3 % which obviously is an unrealistic figure. The v...
| Other Authors: | |
|---|---|
| Format: | Text |
| Language: | English |
| Subjects: | |
| Online Access: | http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.673.537 http://apiindia.org/medicine_update_2013/chap160.pdf |
| Summary: | however, is not that common. It is quite rare. One million Americans and a quarter million of British are said to be suffering from CFS. Some have estimated the prevalence to be 7 cases per 100,000 whereas some think it is much more prevalent—up to 3 % which obviously is an unrealistic figure. The various figures of prevalence suffer from a selection bias. Women are said to be more affected then man. There are no real population-based studies available from India that can give a picture of actual prevalence of this condition in the population. What early studies we get from India (Goa particularly) tries to grapple with the problem of trying to find a prototype an Indian female patient suffering from CFS (with some success) (Source: Chronic fatigue in developing countries: population based survey of women in India. BMJ. 2005;330:1190.). Beyond saying that it is a condition being increasingly recognized by Indian doctors any estimation about its prevalence in our country would be pure guesswork at the present. It will not possibly be incorrect to say that serious clinical search and research on CFS has started in India in the last decade only. NO CONSENSUS ON NOMENCLATURE Internationally, there is yet no consensus regarding nomenclature of this disease condition. The commonly used name is CFS (Source: J Intern Med. 245.). Other names that are proposed by different groups at different times are: • Myalgic encephalomyelitis (ME) • Post-viral fatigue syndrome (PVFS) • Akureyri disease • Benign myalgic encephalomyelitis • Chronic fatigue immune dysfunction syndrome • Chronic infectious mononucleosis. In the United Kingdom to effect a compromise between the two major groups a compromise was reached to call this condition as CFS/ME whether this compromise effort has a sound scientific basis and whether it will hold; only time can tell. It will possibly be simple to use the name CFS only because a name need not always reflect the pathogenesis hypothesis. |
|---|